Related Experiment Video
Updated: Jul 28, 2026

Assessing Cortical Cerebral Microinfarcts on High Resolution MR Images
Published on: November 20, 2015
Cerebral microbleeds in patients with COVID-19: is there an inevitable connection?
Yuchang Wang1, Yuetao Hu1, Ruichen Zhao1
1Department of Neurosurgery, Tianjin Neurological Institute, State Key Laboratory of Experimental Hematology, Key Laboratory of Post-Neuroinjury Neurorepair and Regeneration in Central Nervous System Tianjin & Ministry of Education, Tianjin Medical University General Hospital, Tianjin 300052, China.
Abstract:
The COVID-19 pandemic has underscored the critical interplay between systemic infections and neurological complications, notably cerebral microbleeds. This comprehensive review meticulously aggregates and analyses current evidence on cerebral microbleeds' prevalence, pathophysiological underpinnings and clinical implications within COVID-19 cohorts. Our findings reveal a pronounced correlation between cerebral microbleeds and increased severity of COVID-19, emphasizing the role of direct viral effects, inflammatory responses and coagulation disturbances. The documented association between cerebral microbleeds and elevated risks of morbidity and mortality necessitates enhanced neurological surveillance in managing COVID-19 patients. Although variability in study methodologies presents challenges, the cumulative evidence substantiates cerebral microbleeds as a critical illness manifestation rather than mere coincidence. This review calls for harmonization in research methodologies to refine our understanding and guide targeted interventions. Prioritizing the detection and study of neurological outcomes, such as cerebral microbleeds, is imperative for bolstering pandemic response strategies and mitigating the long-term neurological impact on survivors.
Insights
COVID-19 is linked to cerebral microbleeds, small brain hemorrhages. These bleeds correlate with severe illness and higher mortality risk, requiring increased neurological monitoring for patients.
Area of Science:
- Neurology
- Infectious Diseases
- Vascular Medicine
Background:
- The COVID-19 pandemic highlighted neurological complications of systemic infections.
- Cerebral microbleeds are increasingly recognized in patients with COVID-19.
Purpose of the Study:
- To review and analyze the prevalence, pathophysiology, and clinical implications of cerebral microbleeds in COVID-19 cohorts.
- To synthesize current evidence on the association between cerebral microbleeds and COVID-19 severity.
Main Methods:
- Comprehensive literature review and analysis of existing studies on COVID-19 and cerebral microbleeds.
- Aggregation of data on prevalence, risk factors, and outcomes.
Main Results:
- Cerebral microbleeds are significantly correlated with increased COVID-19 severity.
- Pathophysiological mechanisms include direct viral effects, inflammation, and coagulation disturbances.
- Association with elevated morbidity and mortality risks is documented.
Conclusions:
- Cerebral microbleeds are a critical manifestation in severe COVID-19, not coincidental.
- Enhanced neurological surveillance is crucial for managing COVID-19 patients.
- Methodological harmonization is needed to advance understanding and interventions for neurological outcomes.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

